Global Clinical Chemistry Analyzers Market 2024-2028
Global Clinical Chemistry Analyzers Market 2024-2028
The clinical chemistry analyzers market is forecasted to grow by USD 3327.1 mn during 2023-2028, accelerating at a CAGR of 4.4% during the forecast period. The report on the clinical chemistry analyzers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in new launches of clinical chemistry analyzers by market vendors, rise in awareness regarding point-of-care testing, and increasing prevalence of chronic diseases.
Technavio's clinical chemistry analyzers market is segmented as below:
By End-user
- Hospitals
- Diagnostic laboratories
- Academic research centers
- Others
By Type
- Fully automated clinical chemical analyzers
- Semi automated clinical chemical analyzers
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the rise in adoption of automated clinical chemistry analyzers as one of the prime reasons driving the clinical chemistry analyzers market growth during the next few years. Also, growing demand for personalized medicine and rising demand for multi-analyte testing and comorbidity diagnosis will lead to sizable demand in the market.
The report on the clinical chemistry analyzers market covers the following areas:
- Clinical chemistry analyzers market sizing
- Clinical chemistry analyzers market forecast
- Clinical chemistry analyzers market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical chemistry analyzers market vendors that include Abbott Laboratories, Arkray USA Inc., Balio Diagnostics, Bio Rad Laboratories Inc., Cardinal Health Inc., Chengdu Seamaty Technology Co. Ltd., Danaher Corp., DiaSorin SpA, Dirui Industrial Co. Ltd, Erba Group, F. Hoffmann La Roche Ltd., Hitachi Ltd., HORIBA Ltd., Maccura Biotechnology Co. Ltd, Meril Life Sciences Pvt. Ltd., Randox Laboratories Ltd., Shenzhen Mindray BioMedical Electronics Co. Ltd, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Werfenlife SA. Also, the clinical chemistry analyzers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.